| 000 | 01738 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515023005.0 | ||
| 264 | 0 | _c20060601 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/503437 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBreen, Ronan A M | |
| 245 | 0 | 0 |
_aVirological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cMay 2006 |
||
| 300 |
_a1437-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHIV Infections |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLondon |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Records |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aMiller, R F | |
| 700 | 1 | _aGorsuch, T | |
| 700 | 1 | _aSmith, C J | |
| 700 | 1 | _aAinsworth, J | |
| 700 | 1 | _aBallinger, J | |
| 700 | 1 | _aSwaden, L | |
| 700 | 1 | _aCropley, I | |
| 700 | 1 | _aJohnson, M A | |
| 700 | 1 | _aLipman, M C I | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 193 _gno. 10 _gp. 1437-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/503437 _zAvailable from publisher's website |
| 999 |
_c16223892 _d16223892 |
||